Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic Taussig Cancer Institute
Avatar

Somatic Mutations in MDS as a Diagnostic (ICUS, CHIP, CCUS) and Prognostic Tool

By Cleveland Clinic Taussig Cancer Institute FEATURING Valeria Santini
By Cleveland Clinic Taussig Cancer Institute FEATURING Valeria Santini
140 views
December 12, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

03:15
Lilly Medical Affairs

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
MDS/MPN
10:06

New Therapeutic Targets Beyond JAK-STAT Inhibition in the Treatment …

Cleveland Clinic Taussig Cancer Institute

A. Gerds

399 views
16:58

JAK-STAT Inhibition in the Treatment of Ph-Negative MPN: What Are th…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

264 views
30:31

Somatic Mutations in MDS as a Diagnostic (ICUS, CHIP, CCUS) and Prog…

Cleveland Clinic Taussig Cancer Institute

V. Santini

140 views
28:01

The Changing Genomic Landscape of MPNs: Impact on Clinical Care

Cleveland Clinic Taussig Cancer Institute

L. Michaelis

162 views
07:40

MPN, MDS and Aplastic Anemia Case Discussions

Cleveland Clinic Taussig Cancer Institute

L. Michaelis

426 views
28:08

Rationale and Early Results of Innate Immunity and Immune Check Poin…

Cleveland Clinic Taussig Cancer Institute

G. Garcia-Manero

117 views
14:50

Novel Therapies Beyond Single Agent JAK Inhibitors: New Therapies an…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

302 views